Research review
Does berberine help with infection? What the research does and doesn't show
No human trial supports berberine for yeast infections, UTIs, COVID-19 or the flu. The only relevant human evidence is decades-old trials of berberine sulfate, a different salt, against acute bacterial diarrhea at 400 mg to 1.2 g doses.
The evidence doesn't support berberine as a treatment for yeast infections, UTIs or COVID-19 — no human trial has tested any of those. What has been tested, decades ago, is berberine against acute bacterial diarrhea, at 400–1,200 mg doses of a different berberine salt than most extract capsules use today.
What the evidence doesn't support
It doesn't support berberine for yeast infections, urinary tract infections, COVID-19 or the flu — none of those has been tested in a human trial. The antifungal and antiviral activity sometimes cited for berberine comes from laboratory and mechanistic research, not from a trial in people, and none of it establishes a dose that would do anything in someone taking a supplement.
What the trials found
The clearest human data is decades old and specific to acute bacterial diarrhea. In a 1985 randomized, double-blind trial in the BMJ, 400 adults hospitalized with acute watery diarrhea (185 with confirmed cholera) were randomized to berberine, tetracycline, both, or placebo — this design is noted here only because the trial included a medication arm, not to compare the two. Berberine alone showed no antisecretory effect against cholera on the trial's main measure; a secondary statistical analysis found a smaller reduction in stool volume and a drop in a gut-secretion marker. Neither treatment helped the 215 patients whose diarrhea wasn't caused by cholera. A separate 1987 randomized trial in the Journal of Infectious Diseases gave 165 adults with diarrhea from cholera or toxin-producing E. coli a single 400 mg dose of berberine sulfate: in the E. coli group, stool volume was lower and more people stopped having diarrhea within 24 hours (42% vs 20% of controls). In the cholera group, the same trial also tested a 1,200 mg dose combined with tetracycline, as a separate arm.
Those trials used berberine sulfate, a different salt than the berberine HCl used in most extract capsules today, at single or short-course doses of 400 mg to 1.2 g in adults hospitalized with acute infectious diarrhea — a different population, form and dose than a daily wellness supplement. A 2026 pharmacology review describes berberine's antibacterial, antifungal and antiviral activity broadly, but as a mechanism to be studied further for "clinical development," not as an established treatment; it doesn't report a human trial against a fungal, viral or urinary infection.
Questions people ask
Can berberine cause a yeast infection?
There's no research either way. No trial has looked at whether berberine causes, prevents or treats a yeast infection in people.
Does berberine help with urinary tract infections?
No human trial has tested berberine against a UTI. The infection research that exists is about bacterial diarrhea, not the urinary tract.
Does berberine help with COVID-19 or the flu?
No clinical trial supports that. Laboratory research on berberine's antiviral activity doesn't translate into a tested effect against COVID-19, influenza or flu-like illness in people.
Why do some people report flu-like symptoms after starting berberine?
That's not something the safety research reviewed for this ingredient documents specifically — the side effects best supported by trial data are digestive (diarrhea, constipation, nausea), not flu-like symptoms. See berberine side effects for what's actually reported. Any new or unusual symptom after starting a supplement is worth stopping for and checking with a doctor.
When to talk to a doctor
Berberine is not a treatment for a yeast infection, a UTI, COVID-19, the flu or any other infection. An infection that needs diagnosis or treatment — fever, pain, unusual discharge, or symptoms that don't resolve — is a reason to see a doctor, not a reason to try a supplement instead. Anyone taking a prescription medication, or who is pregnant or nursing, should also check with a doctor before starting berberine.
Related reading: berberine side effects: what's actually reported, who should not take berberine, and berberine: what the research does and doesn't show.
Sources
- Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae In hospitalized adults with acute bacterial diarrhea, a single 400 mg dose of berberine sulfate reduced stool volume and shortened diarrhea from E. coli, with a smaller effect against cholera.
- Clinical trial of berberine in acute watery diarrhoea In hospitalized adults with acute watery diarrhea, berberine showed no clear antisecretory effect against cholera on the trial's primary measure, and no benefit at all for diarrhea not caused by cholera.
- Berberine as an Antimicrobial Agent and Gut Microbiota Modulator: Mechanisms and Therapeutic Potential A 2026 review describes berberine's broad antimicrobial activity mostly in mechanistic terms, aimed at future research, without reporting a human trial against a fungal, viral or urinary infection.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.